Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next …

Arterial Remodeling Technologies reported from the podium yesterday at ‘TCT 2013’ that the Company has successfully completed the 30-day milestone portion of the “ARTDIVA” clinical trial of its novel bioresorbable stent.
Remodeling – Yahoo News Search Results

Short URL:

Posted by on Oct 29 2013. Filed under Remodeling. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

Photo Gallery

Log in | Designed by Buy Websites

Disclaimer : All content including images in this site is copyright to their rightful owners. No copyright infringement is intended.